Lycobetaine
Alternative Names: AT 1840; Lycobetaine acetate; Ungeremine acetate; Ungerimine acetateLatest Information Update: 20 Jul 2006
At a glance
- Originator Nonindustrial sources
- Class Alkaloids; Antineoplastics; Indolizines; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Mitosis inhibitors; RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 20 Jul 2006 No development reported - Preclinical for Cancer in Germany (unspecified route)
- 05 Sep 2002 No development reported - Phase-I for Cancer in China (unspecified route)
- 24 Jan 2001 Preclinical trials in Cancer in Germany (unspecified route)